BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11742892)

  • 41. Lipid metabolism.
    de Bruin TW
    Curr Opin Lipidol; 1998 Jun; 9(3):275-8. PubMed ID: 9645511
    [No Abstract]   [Full Text] [Related]  

  • 42. [Should apolipoproteins be the first choice in routine health care?].
    Järhult B; Lindström K
    Lakartidningen; 2007 Oct 17-23; 104(42):3124. PubMed ID: 17985715
    [No Abstract]   [Full Text] [Related]  

  • 43. [Determination of apolipoproteins: An important tool for prevention and treatment of cardiovascular diseases].
    Wiklund O
    Lakartidningen; 2007 May 14-29; 104(20-21):1623-4. PubMed ID: 17564272
    [No Abstract]   [Full Text] [Related]  

  • 44. Hyperinsulinemia is associated with increased production rate of intestinal apolipoprotein B-48-containing lipoproteins in humans.
    Duez H; Lamarche B; Uffelman KD; Valero R; Cohn JS; Lewis GF
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1357-63. PubMed ID: 16614317
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A review of the familial hyperlipidemias.
    Caldwell AL
    J Med Assoc Ga; 1989 Apr; 78(4):218-20. PubMed ID: 2654317
    [No Abstract]   [Full Text] [Related]  

  • 46. Familial combined hyperlipidemia: upstream transcription factor 1 and beyond.
    Lee JC; Lusis AJ; Pajukanta P
    Curr Opin Lipidol; 2006 Apr; 17(2):101-9. PubMed ID: 16531745
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantitative trait loci for apolipoprotein B, cholesterol, and triglycerides in familial combined hyperlipidemia pedigrees.
    Cantor RM; de Bruin T; Kono N; Napier S; van Nas A; Allayee H; Lusis AJ
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1935-41. PubMed ID: 15308552
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Familial combined hyperlipidaemia: 1973-1991.
    Castro Cabezas M; de Bruin TW; Erkelens DW
    Neth J Med; 1992 Feb; 40(1-2):83-95. PubMed ID: 1579191
    [No Abstract]   [Full Text] [Related]  

  • 49. [Measurement of apolipoproteins is better than routinely measured traditional lipids].
    Kallner A; Estonius M
    Lakartidningen; 2006 Mar 8-14; 103(10):753-6, 758. PubMed ID: 16610202
    [No Abstract]   [Full Text] [Related]  

  • 50. [Levels of apoproteins B, A1 and CIII as markers for cardiovascular risk in lean and obese adolescents].
    Fernández V; Morales LM; Molero-Conejo E; Casanova A; Campos G; Raleigh X; Gómez ME; Ryder E
    Invest Clin; 2004 Mar; 45(1):29-42. PubMed ID: 15058756
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Final reply on the introduction of apolipoprotein determination in Jonkoping: need of ethical platform in the county council].
    Järhult B; Lindahl SO; Lindström K
    Lakartidningen; 2007 Mar 28-Apr 3; 104(13):1065. PubMed ID: 17476915
    [No Abstract]   [Full Text] [Related]  

  • 52. Familial combined hyperlipoproteinemia: experts panel position on diagnostic criteria for clinical practice. Committee of experts of the Atherosclerosis and Dysmetabolic Disorders Study Group.
    Gaddi A; Galetti C; Pauciullo P; Arca M
    Nutr Metab Cardiovasc Dis; 1999 Dec; 9(6):304-11. PubMed ID: 10765523
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Congenital defects of post-heparin lipoprotein lipase. Diagnosis of familial combined lipoproteinemia].
    Titov VN
    Klin Lab Diagn; 2003 Jun; (6):10-7. PubMed ID: 12910637
    [No Abstract]   [Full Text] [Related]  

  • 54. New technologies for delineating and characterizing the lipid exome: prospects for understanding familial combined hyperlipidemia.
    Horswell SD; Ringham HE; Shoulders CC
    J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S370-5. PubMed ID: 19023136
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Familial combined hyperlipidemia].
    Mabuchi H; Nohara A; Nozue T; Koizumi J; Uno Y
    Nihon Naika Gakkai Zasshi; 2001 Aug; 90(8):1538-43. PubMed ID: 11573278
    [No Abstract]   [Full Text] [Related]  

  • 56. Congenital goiter and secondary hyperlipidemia.
    Okten A; Mocan H; Erduran E; Uçar B; Gedik Y
    Acta Paediatr; 1994 Jan; 83(1):125. PubMed ID: 8193464
    [No Abstract]   [Full Text] [Related]  

  • 57. [Dyslipidemic hypertension].
    Cambien F
    Rev Prat; 1988 Oct; 38(22):1558-9. PubMed ID: 3206140
    [No Abstract]   [Full Text] [Related]  

  • 58. Familial combined hyperlipidemia and insulin resistance.
    Frohlich J; Sniderman A
    Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):2100-1. PubMed ID: 11742892
    [No Abstract]   [Full Text] [Related]  

  • 59. [Apolipoprotein B].
    Yamamura T
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():105-9. PubMed ID: 15658275
    [No Abstract]   [Full Text] [Related]  

  • 60. Familial combined hyperlipidemia: controversial aspects of its diagnosis and pathogenesis.
    Aguilar Salinas CA; Zamora M; Gómez-Díaz RA; Mehta R; Gómez Pérez FJ; Rull JA
    Semin Vasc Med; 2004 May; 4(2):203-9. PubMed ID: 15478042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.